Recently, we have investigated the anti-tumor effects of birinapant in HPV(−) HNSCC cells, and observed that cells retaining FADD/BIRC2 amplification and overexpression were sensitive to birinapant, and the effects were enhanced by death agonists TNFα or TRAIL23. Here, BIRC2 is linked to head and neck squamous cell carcinoma.